{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-001496","form_type":"8-K","ticker":"LPTH","cik":"0000889971","company_name":"LIGHTPATH TECHNOLOGIES INC","filed_at":"2024-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.187166+00:00","generated_at":"2026-06-06T06:12:45.489630+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LightPath Q2 FY2024: $7.3M revenue, $1.7M net loss; backlog $21.2M; Lockheed Martin $4.7M order","bullets":["Revenue $7.3M; net loss $1.7M; EBITDA loss $0.5M for Q2 ended Dec 31, 2023.","Total backlog $21.2M; received initial $4.7M order from Lockheed Martin partnership for Army infrared camera program.","Secured renewal order of $3.4M for advanced infrared optics, a 36% increase from initial order.","Completed $5M expansion of Orlando facility, increasing footprint from 34,000 to 55,000 sq ft.","CEO: production decision for Lockheed Martin program moved to 2026; ASP $5K-$10K per system; potential tens of thousands of units."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-001496","json":"https://secwatch.observer/filing/0001654954-24-001496.json","markdown":"https://secwatch.observer/filing/0001654954-24-001496.md","text":"https://secwatch.observer/filing/0001654954-24-001496.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/889971/000165495424001496/0001654954-24-001496-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/889971/000165495424001496/lpth_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T06:12:45.489630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7f671c6724f002835ee4f3b1802c7c3d00288d48","claim":"LIGHTPATH TECHNOLOGIES INC reported fiscal 2024 second quarter ended December 31, 2023 results: revenue Revenue of $7.3 million, net income Net loss for the second quarter of fiscal 2024 was $1.7 million.","evidence_excerpt":"and medical industries, today announced financial results for its fiscal 2024 second quarter ended December 31, 2023. Fiscal 2024 Second Quarter Highlights: · Revenue of $7.3 million for the second quarter of fiscal 2024 · Total backlog at December 31, 2023 of $21.2 million · Net loss for the second quarter of fiscal 2024 was $1.7 million · EBITDA* loss for","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/889971/000165495424001496/0001654954-24-001496-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal 2024 second quarter ended December 31, 2023"},{"label":"Revenue","value":"Revenue of $7.3 million"},{"label":"Net income","value":"Net loss for the second quarter of fiscal 2024 was $1.7 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}